PL2338484T3 - Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych - Google Patents

Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych

Info

Publication number
PL2338484T3
PL2338484T3 PL10193040T PL10193040T PL2338484T3 PL 2338484 T3 PL2338484 T3 PL 2338484T3 PL 10193040 T PL10193040 T PL 10193040T PL 10193040 T PL10193040 T PL 10193040T PL 2338484 T3 PL2338484 T3 PL 2338484T3
Authority
PL
Poland
Prior art keywords
administration
structured lipids
imprinting effect
metabolic imprinting
metabolic
Prior art date
Application number
PL10193040T
Other languages
English (en)
Inventor
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Annemarie Oosting
Martine Sandra Alles
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42537756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2338484(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2338484T3 publication Critical patent/PL2338484T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10193040T 2009-12-11 2010-11-30 Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych PL2338484T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2009/050757 WO2011071367A1 (en) 2009-12-11 2009-12-11 Metabolic imprinting effects of structured lipids
EP10193040A EP2338484B1 (en) 2009-12-11 2010-11-30 Metabolic imprinting effects of structured lipids

Publications (1)

Publication Number Publication Date
PL2338484T3 true PL2338484T3 (pl) 2013-07-31

Family

ID=42537756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10193040T PL2338484T3 (pl) 2009-12-11 2010-11-30 Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych

Country Status (10)

Country Link
US (1) US9044446B2 (pl)
EP (1) EP2338484B1 (pl)
CN (1) CN102724976B (pl)
BR (1) BR112012014028A2 (pl)
ES (1) ES2407081T3 (pl)
MY (1) MY160492A (pl)
PH (1) PH12012501136A1 (pl)
PL (1) PL2338484T3 (pl)
RU (1) RU2558853C2 (pl)
WO (2) WO2011071367A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
AR086993A1 (es) 2011-06-20 2014-02-05 Gen Biscuit Masa de galletita
EP2805717A4 (en) * 2012-01-19 2015-06-10 Nippon Suisan Kaisha Ltd APPETITE IN HOUR
EP2845490A1 (en) * 2013-09-05 2015-03-11 Loders Croklaan B.V. Fat composition for improved body fat distribution
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
CN105028659B (zh) * 2015-05-14 2018-10-30 江南大学 一种人乳替代脂组合物
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN108366986A (zh) 2015-10-15 2018-08-03 N·V·努特里奇亚 用于促进健康生长的具有乳脂的婴儿配方物
US20210392934A1 (en) * 2016-03-10 2021-12-23 Enzymotec Ltd. Lipid compositions and uses thereof
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
WO2018178302A1 (en) 2017-03-29 2018-10-04 N.V. Nutricia Infant formula for improved eating behaviour
CN112087956A (zh) * 2018-04-03 2020-12-15 N·V·努特里奇亚 用于预防干性皮肤的营养组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1465003A1 (ru) * 1987-06-25 1989-03-15 Всесоюзный научно-исследовательский и конструкторский институт молочной промышленности Способ производства адаптированного кисломолочного продукта дл детского питани
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
JP2761294B2 (ja) 1993-05-13 1998-06-04 ロデルス−クロクラーン エステル交換トリグリセリドブレンド由来のヒト母乳脂肪代用品
US5686491A (en) * 1994-09-14 1997-11-11 Sigma-Tau Pharmaceuticals, Inc. Infant formula
EP1062873A1 (en) 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
EP2351492B1 (en) * 2005-02-28 2014-08-20 N.V. Nutricia Nutritional composition with probiotics
RU2413430C2 (ru) * 2005-04-27 2011-03-10 Энзимотек Лтд. Композиция жировой основы (варианты) и способ ее получения (варианты), композиция заменителя жира женского молока и способ ее получения (варианты), смесь для детского питания
ES2537080T3 (es) 2005-12-23 2015-06-02 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas y manganeso y/o molibdeno para mejorar la composición de membranas celulares
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
BRPI0818079B8 (pt) * 2007-10-09 2021-07-27 Enzymotec Ltd composição de lipídeo
FR2927771B1 (fr) * 2008-02-27 2012-05-25 Henry Dabadie Composition dietetique a base de lait et son application pour le traitement de la surcharge ponderale, de l'obesite ou du syndrome metabolique
CN101978321B (zh) * 2008-03-21 2013-06-12 旭化成电子材料株式会社 感光性树脂组合物、感光性树脂层压体、抗蚀图案形成方法、以及印刷线路板、引线框、半导体封装体和凹凸基板的制造方法

Also Published As

Publication number Publication date
EP2338484A1 (en) 2011-06-29
PH12012501136A1 (en) 2012-10-22
BR112012014028A2 (pt) 2017-12-12
US9044446B2 (en) 2015-06-02
CN102724976B (zh) 2014-10-22
RU2558853C2 (ru) 2015-08-10
MY160492A (en) 2017-03-15
ES2407081T3 (es) 2013-06-11
US20120322756A1 (en) 2012-12-20
WO2011071371A1 (en) 2011-06-16
WO2011071367A1 (en) 2011-06-16
RU2012129272A (ru) 2014-01-20
EP2338484B1 (en) 2013-02-13
CN102724976A (zh) 2012-10-10

Similar Documents

Publication Publication Date Title
PL2338484T3 (pl) Efekt imprintingu metabolicznego po podaniu lipidów strukturyzowanych
IL290077A (en) Improved lipid formulation
CY20222200002T2 (el) Βιοαποικοδομησιμα λιπιδια για την απελευθερωση δραστικων παραγοντων
IL283459B (en) Novel lipids and compositions for the delivery of therapeutics
PL2720562T3 (pl) Wpływ imprintingu metabolicznego specjalnie zaprojektowanego składnika lipidowego
EP2790736A4 (en) IN VIVO ADMINISTRATION OF OLIGONUCLEOTIDES
EP2786790A4 (en) COMBINED SEPARATE TOY CIRCLE
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
PT2493478T (pt) Composições terapêuticas concentradas de fosfolípidos
DK2371238T3 (da) Tredimensionel ansigtsmaske
EP2720699A4 (en) ADMINISTRATION OF BENZODIAZEPINE
HUE051570T2 (hu) Liposzómák biszfoszfonát és amfipatikus szer együtt kapszulázásához
EP2758052A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2691100A4 (en) INTRANASAL PHARMACEUTICAL BENZODIAZEPINE COMPOSITIONS
CO6950486A2 (es) Solución para administración oral
BR112013024959A2 (pt) sn-1(3) monoacilglicerídeos e absorção de lipídeo
CO6940426A2 (es) Formulaciones farmacéuticas
EP2557629A4 (en) Cylindrical plasma resonant cavity
EP2769718A4 (en) MEDICAL COMPOSITION
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
EP2687212A4 (en) DRUG
EP2714715A4 (en) PHARMACEUTICAL COMPOSITIONS
ES1070583Y (es) Dispositivo para facilitar la introduccion de mascarilla laringea
EP2768489A4 (en) PHARMACEUTICAL COMPOSITIONS OF RESVERATROL